WASHINGTON, D.C. — Federal health officials have pushed back key deadlines for a new Medicaid drug pricing initiative after strong interest from pharmaceutical manufacturers and state programs.
What This Means for You
- Drugmakers and states have more time to join a new pricing model
- The program aims to lower prescription drug costs in Medicaid
- States could gain access to internationally aligned pricing
The Centers for Medicare & Medicaid Services announced extensions for applications and participation agreements tied to the GENEROUS Model, a federal initiative designed to reduce prescription drug costs in Medicaid.
The model — short for Generating Cost Reductions for U.S. Medicaid — allows participating states to purchase certain medications at prices aligned with those paid in select other countries, potentially lowering costs for public health programs.
New Deadlines Announced
CMS extended the application deadline for drug manufacturers to June 11, 2026, from April 30, 2026. The deadline for manufacturers to finalize participation agreements was also pushed to July 17, 2026.
State Medicaid programs will have additional time as well. Their application deadline has been extended to September 10, 2026, with final participation agreements now due by September 30, 2026.
Officials said the changes are intended to give manufacturers — particularly small- and mid-sized companies — more time to review requirements and prepare applications.
How the Program Works
The GENEROUS Model is part of the CMS Innovation Center’s efforts to test new ways to control healthcare costs.
Under the model, drug manufacturers that participate in the Medicaid Drug Rebate Program can opt in to offer their products through the initiative. In return, participating state Medicaid programs gain access to those drugs at prices benchmarked against international markets.
This approach is intended to create more competitive pricing and improve access to medications for Medicaid beneficiaries.
Next Steps
CMS said interested manufacturers can contact the agency to schedule informational meetings as they consider participation.
The program, first announced in November 2025, remains voluntary for both manufacturers and states, with final participation decisions expected later this year following the extended deadlines.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.